272 results on '"Bartlett, Nathan W."'
Search Results
2. Airway-delivered short-chain fatty acid acetate boosts antiviral immunity during rhinovirus infection
3. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
4. IL-25 blockade augments antiviral immunity during respiratory virus infection
5. Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-Modifying Therapies
6. Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease
7. Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection
8. Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics
9. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
10. An Update in Club Cell Biology and Its Potential Relevance to Chronic Obstructive Pulmonary Disease
11. Call for Papers: “Targeting Airway Immunity in Lung Disease”
12. Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level
13. Call for Papers: “In It for the Long Haul: Understanding the Lasting Impact of COVID-19 on Lung Health and Disease”
14. A persistent neutrophil-associated immune signature characterizes post–COVID-19 pulmonary sequelae
15. Conditionally reprogrammed asthmatic bronchial epithelial cells express lower FOXJ1 at terminal differentiation and lower IFNs following RV-A1 infection
16. Respiratory Viruses and Asthma
17. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
18. Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1
19. RSV-Induced Bronchial Epithelial Cell PD-L1 Expression Inhibits CD8⁺ T Cell Nonspecific Antiviral Activity
20. Understanding Rhinovirus Circulation and Impact on Illness
21. Pulmonary Innate Lymphoid Cell Responses during Rhinovirus-induced Asthma ExacerbationsIn Vivo: A Clinical Trial
22. A cGAS-dependent response links DNA damage and senescence in alveolar epithelial cells: a potential drug target in IPF
23. Promoting our early career members at AJP-Lung: The Editorial Board Fellowship Program and the Next Generation Physiologist Highlights section at our Journal
24. Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia
25. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity
26. IL-33-Dependent Type 2 Inflammation during Rhinovirus-induced Asthma Exacerbations In Vivo
27. Mouse Models of Rhinovirus Infection and Airways Disease
28. Announcing the Editorial Board Fellowship Program of the American Journal of Physiology-Lung Cellular and Molecular Physiology
29. The microbiology of asthma
30. Beclomethasone Has Lesser Suppressive Effects on Inflammation and Antibacterial Immunity Than Fluticasone or Budesonide in Experimental Infection Models
31. miR-122 promotes virus-induced lung disease by targeting SOCS1
32. Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients
33. TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs
34. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6
35. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
36. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation
37. Role of deficient type III interferon-[lambda] production in asthma exacerbations
38. The influence of asthma control on the severity of virus-induced asthma exacerbations
39. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
40. TLR2-mediated innate immune priming boosts lung anti-viral immunity
41. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells
42. A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation
43. Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus
44. Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo
45. Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
46. Airway mechanical compression: its role in asthma pathogenesis and progression
47. Seroprevalence of Torque Teno Virus in hemodialysis and renal transplant patients in Australia: A cross‐sectional study
48. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
49. Airway Epithelial Cell Immunity Is Delayed During Rhinovirus Infection in Asthma and COPD
50. The role of growth factor receptors in viral infections: An opportunity for drug repurposing against emerging viral diseases such as COVID‐19?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.